Cargando…

Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a variable course. Not uncommonly, IPF patients are hospitalized for respiratory-related causes, including disease worsening. This study aimed to characterize the prevalence, and economic and health care burden of IPF. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raimundo, Karina, Chang, Eunice, Broder, Michael S., Alexander, Kimberly, Zazzali, James, Swigris, Jeffrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702364/ https://www.ncbi.nlm.nih.gov/pubmed/26732054 http://dx.doi.org/10.1186/s12890-015-0165-1

Ejemplares similares

Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden
por: Mooney, Joshua J., et al.
Publicado: (2017)

Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
por: Mooney, Joshua, et al.
Publicado: (2019)

Transitions and touchpoints in idiopathic pulmonary fibrosis
por: Swigris, Jeffrey J
Publicado: (2018)

Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire
por: Swigris, Jeffrey J., et al.
Publicado: (2020)

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
por: Broder, Michael S., et al.
Publicado: (2015)

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2018)

A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis
por: Mooney, Joshua, et al.
Publicado: (2021)

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives
por: Swigris, Jeffrey J, et al.
Publicado: (2005)

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
por: Cox, Ingrid A., et al.
Publicado: (2022)

Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis
por: Olson, Amy L, et al.
Publicado: (2016)

Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis
por: Yu, Yanni F., et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers
por: Ramadurai, Deepa, et al.
Publicado: (2019)

The psychometric properties of the St George’s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review
por: Swigris, Jeffrey J, et al.
Publicado: (2014)

The need for patient-centred clinical research in idiopathic pulmonary fibrosis
por: Russell, Anne-Marie, et al.
Publicado: (2015)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Cao, Mengshu, et al.
Publicado: (2016)

4569 Burden of illness in idiopathic pulmonary fibrosis: A real-world cohort
por: Farrand, Erica, et al.
Publicado: (2020)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
por: Reddy, Sheila R., et al.
Publicado: (2020)

Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials
por: Swigris, Jeffrey J, et al.
Publicado: (2018)

Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)
por: Rodríguez-Nieto, Maria Jesus, et al.
Publicado: (2023)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

PB2154: THE IMPACT OF DISEASE SEVERITY ON THE CLINICAL AND ECONOMIC BURDEN OF AL AMYLOIDOSIS
por: D’souza, Anita, et al.
Publicado: (2023)

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease
por: Pan, Rui-Li, et al.
Publicado: (2018)

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
por: Song, Myung Jin, et al.
Publicado: (2021)

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review
por: Diamantopoulos, Alex, et al.
Publicado: (2018)

Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database
por: Corral, Mitra, et al.
Publicado: (2015)

Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)
por: Yorke, Janelle, et al.
Publicado: (2014)

Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
por: Marijic, Pavo, et al.
Publicado: (2021)

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
por: Horio, Yukihiro, et al.
Publicado: (2022)

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
por: Holtze, Colin H., et al.
Publicado: (2020)

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
por: Jovanovic, Dragana M., et al.
Publicado: (2022)

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
por: Organ, Louise A., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
por: Suzuki, Takahito, et al.
Publicado: (2021)

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
por: Suzuki, Yuzo, et al.
Publicado: (2021)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1u16s376up1mgll88cd51965ui